Efficacy and Safety of CRT, Durvalumab and Surgery for SST

Clinical trial NCT04465968 · NOT_YET_RECRUITING

Trial details

NCT number: NCT04465968
Sponsor: National Cancer Center Hospital East
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Superior Sulcus Tumor Non-small Cell Lung Cancer Stage IIB Non Small Cell Lung Cancer Stage III

Start date: 2020-09-01
Primary completion: 2027-08-31
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.